Zydus Lifesciences informs about press release

16 Nov 2022 Evaluate
Zydus Lifesciences has informed that it enclosed press release titled ‘Zydus Lifesciences gets exclusive marketing rights for Can Assist Breast- an innovative prognostic test for breast cancer patients’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.45 -15.80 (-1.76%)
14-Jan-2026 14:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1692.75
Dr. Reddys Lab 1180.70
Cipla 1430.60
Zydus Lifesciences 884.45
Lupin 2214.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×